ConductScience.org, home

Paper1666499

Mechanism of action of sparfloxacin against and mechanism of resistance in gram-negative and gram-positive bacteria.

Piddock LJ and 1 other. Antimicrob Agents Chemother, 1991. Cited by 29 papers, by iCite.

Cite this record

ConductScience Library. Mechanism of action of sparfloxacin against and mechanism of resistance in gram-negative and gram-positive bacteria. Papers, record 1666499. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/1666499

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Mechanism of action of sparfloxacin against and mechanism of resistance in gram-negative and gram-positive bacteria.
PubMed
Journal
Antimicrob Agents Chemother
PubMed
Year
1991
PubMed
Publication types
Journal Article
PubMed
Citations, by iCite
29
iCite
Relative citation ratio, by iCite
1.13
iCite
Revised in PubMed
2021-05-26
PubMed

Authors2

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Piddock LJL J
2Zhu MM

Source PubMed

Download CSV of authors

Topics13

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
FluoroquinolonesMajor topic
Gram-Negative BacteriaMajor topic
Gram-Positive BacteriaMajor topic
QuinolonesMajor topic
Anti-Bacterial Agents
Ciprofloxacin
DNA Probes
DNA, Bacterial
Drug Resistance, Microbial
Enterobacteriaceae
Mutation
Phenotype
Pseudomonas aeruginosa

Source PubMed

Download CSV of topics

References20

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

OrderPMIDTitleJournalYearIn PapersSource
13532944Isolation and characterization of norfloxacin-resistant mutants of Escherichia coli K-12.Antimicrob Agents Chemother1986https://conductscience.org/library/papers/3532944PubMed
22658782Mechanisms of quinolone resistance in Escherichia coli: characterization of nfxB and cfxB, two mutant resistance loci decreasing norfloxacin accumulation.Antimicrob Agents Chemother1989https://conductscience.org/library/papers/2658782PubMed
32110938The accumulation of five quinolone antibacterial agents by Escherichia coli.J Antimicrob Chemother1990https://conductscience.org/library/papers/2110938PubMed
44570289Genetic control of DNA initiation in Escherichia coli.J Mol Biol1973https://conductscience.org/library/papers/4570289PubMed
51708224Correlation of quinolone MIC and inhibition of DNA, RNA, and protein synthesis and induction of the SOS response in Escherichia coli.Antimicrob Agents Chemother1990https://conductscience.org/library/papers/1708224PubMed
62039209In vitro activity of sparfloxacin.Antimicrob Agents Chemother1991https://conductscience.org/library/papers/2039209PubMed
72039202Mechanisms of quinolone resistance in a clinical isolate of Escherichia coli highly resistant to fluoroquinolones but susceptible to nalidixic acid.Antimicrob Agents Chemother1991https://conductscience.org/library/papers/2039202PubMed
82024969Uptake of sparfloxacin and norfloxacin by clinical isolates of Staphylococcus aureus.Antimicrob Agents Chemother1991https://conductscience.org/library/papers/2024969PubMed
91963290Inhibitory effects of quinolones on pro- and eucaryotic DNA topoisomerases I and II.Antimicrob Agents Chemother1990https://conductscience.org/library/papers/1963290PubMed
101963286Broad-host-range gyrase A gene probe.Antimicrob Agents Chemother1990https://conductscience.org/library/papers/1963286PubMed
112127348In vitro activity of sparfloxacin (CI-978; AT-4140) against clinical isolates from cancer patients.Antimicrob Agents Chemother1990https://conductscience.org/library/papers/2127348PubMed
122081717A comparison of the mechanisms of decreased susceptibility of aztreonam-resistant and ceftazidime-resistant Enterobacteriaceae.J Antimicrob Chemother1990https://conductscience.org/library/papers/2081717PubMed
132079449In-vitro activity of sparfloxacin, a new quinolone antimicrobial agent.J Antimicrob Chemother1990https://conductscience.org/library/papers/2079449PubMed
142285304Antistaphylococcal activities of sparfloxacin (CI-978; AT-4140), ofloxacin, and ciprofloxacin.Antimicrob Agents Chemother1990https://conductscience.org/library/papers/2285304PubMed
153015000Effects of norfloxacin on DNA metabolism in Pseudomonas aeruginosa.Antimicrob Agents Chemother1986https://conductscience.org/library/papers/3015000PubMed
163010850Genetic and biochemical characterization of norfloxacin resistance in Escherichia coli.Antimicrob Agents Chemother1986https://conductscience.org/library/papers/3010850PubMed
173056251Association between early inhibition of DNA synthesis and the MICs and MBCs of carboxyquinolone antimicrobial agents for wild-type and mutant [gyrA nfxB(ompF) acrA] Escherichia coli K-12.Antimicrob Agents Chemother1988https://conductscience.org/library/papers/3056251PubMed
182540707Fluorometric assay for fleroxacin uptake by bacterial cells.Antimicrob Agents Chemother1989https://conductscience.org/library/papers/2540707PubMed
192679373
Cross-resistance to fluoroquinolones in multiple-antibiotic-resistant (Mar) Escherichia coli selected by tetracycline or chloramphenicol: decreased drug accumulation associated with membrane changes in addition to OmpF reduction.
Antimicrob Agents Chemother1989https://conductscience.org/library/papers/2679373PubMed
202168142Mechanism of action of lomefloxacin.Antimicrob Agents Chemother1990https://conductscience.org/library/papers/2168142PubMed

Download CSV of references

Cited by14

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 29 citations.

PMIDTitleJournalYearIn PapersSource
41034490Photosensitizer-specific bacterial stress responses in Escherichia coli reveal distinct targets in photoinduced inactivation.Commun Biol2025https://conductscience.org/library/papers/41034490PubMed
36144292A Robust One-Step Recombineering System for Enterohemorrhagic Escherichia coli.Microorganisms2022https://conductscience.org/library/papers/36144292PubMed
34248906A Novel Device-Integrated Drug Delivery System for Local Inhibition of Urinary Tract Infection.Front Microbiol2021https://conductscience.org/library/papers/34248906PubMed
25523502Unique features of apicoplast DNA gyrases from Toxoplasma gondii and Plasmodium falciparum.BMC Bioinformatics2014https://conductscience.org/library/papers/25523502PubMed
12069989Novel ciprofloxacin-resistant, nalidixic acid-susceptible mutant of Staphylococcus aureus.Antimicrob Agents Chemother2002https://conductscience.org/library/papers/12069989PubMed
11850266Accumulation of 10 fluoroquinolones by wild-type or efflux mutant Streptococcus pneumoniae.Antimicrob Agents Chemother2002https://conductscience.org/library/papers/11850266PubMed
10681364
A convenient assay for estimating the possible involvement of efflux of fluoroquinolones by Streptococcus pneumoniae and Staphylococcus aureus: evidence for diminished moxifloxacin, sparfloxacin, and trovafloxacin efflux.
Antimicrob Agents Chemother2000https://conductscience.org/library/papers/10681364PubMed
9098667Sparfloxacin. A review of its antibacterial activity, pharmacokinetic properties, clinical efficacy and tolerability in lower respiratory tract infections.Drugs1997https://conductscience.org/library/papers/9098667PubMed
8843279Gyrase mutations in laboratory-selected, fluoroquinolone-resistant mutants of Mycobacterium tuberculosis H37Ra.Antimicrob Agents Chemother1996https://conductscience.org/library/papers/8843279PubMed
8494360Ciprofloxacin resistance in clinical isolates of Salmonella typhimurium obtained from two patients.Antimicrob Agents Chemother1993https://conductscience.org/library/papers/8494360PubMed
8203834Activity of Bay y3118 against quinolone-susceptible and -resistant gram-negative and gram-positive bacteria.Antimicrob Agents Chemother1994https://conductscience.org/library/papers/8203834PubMed
8192436New quinolones and gram-positive bacteria.Antimicrob Agents Chemother1994https://conductscience.org/library/papers/8192436PubMed
7689446Mechanisms of resistance to quinolones.Drugs1993https://conductscience.org/library/papers/7689446PubMed
1416840Quinolone accumulation in Escherichia coli, Pseudomonas aeruginosa, and Staphylococcus aureus.Antimicrob Agents Chemother1992https://conductscience.org/library/papers/1416840PubMed

Download CSV of cited by

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Grants
  • Trials
  • Comments and corrections
  • Genes
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/1666499

GET https://conductscience.org/api/papers/v1/1666499/authors